{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:26:42Z","timestamp":1778657202117,"version":"3.51.4"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1093\/neuonc\/nou287","type":"journal-article","created":{"date-parts":[[2014,9,23]],"date-time":"2014-09-23T04:27:17Z","timestamp":1411446437000},"page":"670-677","source":"Crossref","is-referenced-by-count":21,"title":["The impact of coexisting genetic mutations on murine optic glioma biology"],"prefix":"10.1093","volume":"17","author":[{"given":"Aparna","family":"Kaul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph A.","family":"Toonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott M.","family":"Gianino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H.","family":"Gutmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,9,21]]},"reference":[{"issue":"(1)","key":"key\n\t\t\t\t20170511102259_NOU287C1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jama.1997.03550010065042","article-title":"The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2","volume":"278","author":"Gutmann","year":"1997","journal-title":"JAMA"},{"issue":"(5)","key":"key\n\t\t\t\t20170511102259_NOU287C2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1177\/0883073813476141","article-title":"Pilocytic astrocytoma: a disease with evolving molecular heterogeneity","volume":"28","author":"Sadighi","year":"2013","journal-title":"J Child Neurol"},{"issue":"(1)","key":"key\n\t\t\t\t20170511102259_NOU287C3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-3476(94)70122-9","article-title":"Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study","volume":"125","author":"Listernick","year":"1994","journal-title":"J Pediatr"},{"issue":"(5)","key":"key\n\t\t\t\t20170511102259_NOU287C4","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0022-3476(89)80137-4","article-title":"Optic gliomas in children with neurofibromatosis type 1","volume":"114","author":"Listernick","year":"1989","journal-title":"J Pediatr"},{"issue":"(3)","key":"key\n\t\t\t\t20170511102259_NOU287C5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ana.21107","article-title":"Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations","volume":"61","author":"Listernick","year":"2007","journal-title":"Ann Neurol"},{"issue":"(2)","key":"key\n\t\t\t\t20170511102259_NOU287C6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ana.410410204","article-title":"Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force","volume":"41","author":"Listernick","year":"1997","journal-title":"Ann Neurol"},{"issue":"(3)","key":"key\n\t\t\t\t20170511102259_NOU287C7","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0022-3476(95)70449-3","article-title":"Precocious puberty in children with neurofibromatosis type 1","volume":"126","author":"Habiby","year":"1995","journal-title":"J Pediatr"},{"issue":"(16)","key":"key\n\t\t\t\t20170511102259_NOU287C8","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1200\/JCO.2005.03.8349","article-title":"Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy","volume":"24","author":"Sharif","year":"2006","journal-title":"J Clin Oncol"},{"issue":"(4)","key":"key\n\t\t\t\t20170511102259_NOU287C9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/neuonc\/2.4.213","article-title":"Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II study","volume":"2","author":"Mahoney","year":"2000","journal-title":"Neuro Oncol"},{"issue":"(5)","key":"key\n\t\t\t\t20170511102259_NOU287C10","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1200\/JCO.1993.11.5.850","article-title":"Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood","volume":"11","author":"Packer","year":"1993","journal-title":"J Clin Oncol"},{"issue":"(3)","key":"key\n\t\t\t\t20170511102259_NOU287C11","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1101\/gr.142604.112","article-title":"Somatic neurofibromatosis type 1 (NF1) inactivation characterizes NF1-associated pilocytic astrocytoma","volume":"23","author":"Gutmann","year":"2013","journal-title":"Genome Res"},{"issue":"(9)","key":"key\n\t\t\t\t20170511102259_NOU287C12","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/jnen\/59.9.759","article-title":"Loss of neurofibromin is associated with activation of RAS\/MAPK and PI3-K\/AKT signaling in a neurofibromatosis 1 astrocytoma","volume":"59","author":"Lau","year":"2000","journal-title":"J Neuropathol Exp Neurol"},{"issue":"(4)","key":"key\n\t\t\t\t20170511102259_NOU287C13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1365-2990.2000.00258.x","article-title":"Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas","volume":"26","author":"Gutmann","year":"2000","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"(24)","key":"key\n\t\t\t\t20170511102259_NOU287C14","first-page":"8573","article-title":"Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity","volume":"63","author":"Bajenaru","year":"2003","journal-title":"Cancer Res"},{"issue":"(24)","key":"key\n\t\t\t\t20170511102259_NOU287C15","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1242\/dev.02162","article-title":"Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation","volume":"132","author":"Zhu","year":"2005","journal-title":"Development"},{"issue":"(1)","key":"key\n\t\t\t\t20170511102259_NOU287C16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ana.20337","article-title":"Natural history of neurofibromatosis 1-associated optic nerve glioma in mice","volume":"57","author":"Bajenaru","year":"2005","journal-title":"Ann Neurol"},{"issue":"(1)","key":"key\n\t\t\t\t20170511102259_NOU287C17","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuroscience.2010.06.017","article-title":"Ultrastructural characterization of the optic pathway in a mouse model of neurofibromatosis-1 optic glioma","volume":"170","author":"Kim","year":"2010","journal-title":"Neuroscience"},{"issue":"(3)","key":"key\n\t\t\t\t20170511102259_NOU287C18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00401-010-0784-9","article-title":"PI3K\/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytoma","volume":"121","author":"Rodriguez","year":"2011","journal-title":"Acta Neuropathol"},{"issue":"(9)","key":"key\n\t\t\t\t20170511102259_NOU287C19","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/NEN.0b013e3182656ef8","article-title":"BRAF duplications and MAPK pathway activation are frequent in gliomas of the optic nerve proper","volume":"71","author":"Rodriguez","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"issue":"(10)","key":"key\n\t\t\t\t20170511102259_NOU287C20","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/dvg.22415","article-title":"Conditional KIAA1549:BRAF mice reveal brain region- and cell type-specific effects","volume":"51","author":"Kaul","year":"2013","journal-title":"Genesis"},{"issue":"(14)","key":"key\n\t\t\t\t20170511102259_NOU287C21","doi-asserted-by":"crossref","first-page":"5100","DOI":"10.1128\/MCB.22.14.5100-5113.2002","article-title":"Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation","volume":"22","author":"Bajenaru","year":"2002","journal-title":"Mol Cell Biol"},{"issue":"(2)","key":"key\n\t\t\t\t20170511102259_NOU287C22","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/gene.10036","article-title":"Cre\/loxP-mediated inactivation of the murine Pten tumor suppressor gene","volume":"32","author":"Lesche","year":"2002","journal-title":"Genesis"},{"issue":"(11)","key":"key\n\t\t\t\t20170511102259_NOU287C23","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/glia.20845","article-title":"Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation","volume":"57","author":"Yeh","year":"2009","journal-title":"Glia"},{"issue":"(2)","key":"key\n\t\t\t\t20170511102259_NOU287C24","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/glia.20036","article-title":"Loss of tuberous sclerosis complex 1 (Tsc1) expression results in increased Rheb\/S6 K pathway signaling important for astrocyte cell size regulation","volume":"47","author":"Uhlmann","year":"2004","journal-title":"Glia"},{"issue":"(1)","key":"key\n\t\t\t\t20170511102259_NOU287C25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ccr.2012.05.036","article-title":"Innate neural stem cell heterogeneity determines the patterning of glioma formation in children","volume":"22","author":"Lee","year":"2012","journal-title":"Cancer Cell"},{"issue":"(10)","key":"key\n\t\t\t\t20170511102259_NOU287C26","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/dvg.22415","article-title":"Conditional KIAA1549:BRAF mice reveal brain region- and cell type-specific effects","volume":"51","author":"Kaul","year":"2013","journal-title":"Genesis"},{"issue":"(5)","key":"key\n\t\t\t\t20170511102259_NOU287C27","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1158\/0008-5472.CAN-07-5916","article-title":"Preclinical cancer therapy in a mouse model of neurofibromatosis-1 optic glioma","volume":"68","author":"Hegedus","year":"2008","journal-title":"Cancer Res"},{"issue":"(19)","key":"key\n\t\t\t\t20170511102259_NOU287C28","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1093\/hmg\/ddn194","article-title":"Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis","volume":"17","author":"Hegedus","year":"2008","journal-title":"Hum Mol Genet"},{"issue":"(21)","key":"key\n\t\t\t\t20170511102259_NOU287C29","doi-asserted-by":"crossref","first-page":"8673","DOI":"10.1158\/0008-5472.CAN-08-2097","article-title":"Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas","volume":"68","author":"Jones","year":"2008","journal-title":"Cancer Res"},{"issue":"(19)","key":"key\n\t\t\t\t20170511102259_NOU287C30","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1212\/WNL.0b013e3181c0664a","article-title":"Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma","volume":"73","author":"Yu","year":"2009","journal-title":"Neurology"},{"issue":"(4)","key":"key\n\t\t\t\t20170511102259_NOU287C31","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1172\/JCI44656","article-title":"An activated mutant BRAF kinase domain is sufficient to induce pilocytic astrocytoma in mice","volume":"121","author":"Gronych","year":"2011","journal-title":"J Clin Invest"},{"issue":"(46)","key":"key\n\t\t\t\t20170511102259_NOU287C32","doi-asserted-by":"crossref","first-page":"19479","DOI":"10.1073\/pnas.0910398106","article-title":"PTEN dosage is essential for neurofibroma development and malinant transformation","volume":"106","author":"Gregorian","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"(13)","key":"key\n\t\t\t\t20170511102259_NOU287C33","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1158\/0008-5472.CAN-11-4092","article-title":"PTEN and NF1 inactivation in Schwann cells produces a severe phenotype in the peripheral nervous system that promotes the development and malignant progression of peripheral nerve sheath tumors","volume":"72","author":"Keng","year":"2012","journal-title":"Cancer Res"},{"issue":"(9)","key":"key\n\t\t\t\t20170511102259_NOU287C34","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1158\/0008-5472.CAN-07-6867","article-title":"Pten haploinsufficiency accelerates formation of high-grade astrocytomas","volume":"68","author":"Kwon","year":"2008","journal-title":"Cancer Res"},{"issue":"(7)","key":"key\n\t\t\t\t20170511102259_NOU287C35","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1158\/0008-5472.CAN-04-4058","article-title":"Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors","volume":"65","author":"Dasgupta","year":"2005","journal-title":"Cancer Res"},{"issue":"(38)","key":"key\n\t\t\t\t20170511102259_NOU287C36","doi-asserted-by":"crossref","first-page":"15996","DOI":"10.1073\/pnas.1019012108","article-title":"Neurofibromatosis-1 regulates mTOR-mediated astrocyte growth and glioma formation in a TSC\/Rheb-independent manner","volume":"108","author":"Banerjee","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170511102259_NOU287C37","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fonc.2013.00110","article-title":"The combination of novel targeted molecular agents and radiation in the treatment of pediatric gliomas","volume":"3","author":"Dasgupta","year":"2013","journal-title":"Front Oncol"},{"issue":"(12)","key":"key\n\t\t\t\t20170511102259_NOU287C38","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/neuonc\/noq103","article-title":"Dual blocking of mTor and PI3K elicits a prodifferentiation effect on glioblastoma stem-like cells","volume":"12","author":"Sunayama","year":"2010","journal-title":"Neuro Oncol"},{"issue":"(6)","key":"key\n\t\t\t\t20170511102259_NOU287C39","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/neuonc\/nos076","article-title":"Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis","volume":"14","author":"Fisher","year":"2012","journal-title":"Neuro Oncol"},{"issue":"(1)","key":"key\n\t\t\t\t20170511102259_NOU287C40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/0883073812439435","article-title":"Attention skills in children with neurofibromatosis type 1","volume":"28","author":"Isenberg","year":"2013","journal-title":"J Child Neurol"},{"issue":"(6)","key":"key\n\t\t\t\t20170511102259_NOU287C41","doi-asserted-by":"crossref","first-page":"e1642","DOI":"10.1542\/peds.2013-1868","article-title":"Neurofibromatosis type 1 and autism spectrum disorder","volume":"132","author":"Garg","year":"2013","journal-title":"Pediatrics"},{"issue":"(4)","key":"key\n\t\t\t\t20170511102259_NOU287C42","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1212\/WNL.48.4.1121","article-title":"Cognitive function and academic performance in neurofibromatosis. 1: consensus statement from the NF1 Cognitive Disorders Task Force","volume":"48","author":"North","year":"1997","journal-title":"Neurology"},{"issue":"(3)","key":"key\n\t\t\t\t20170511102259_NOU287C43","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jamaophthalmol.2013.7649","article-title":"Handheld optical coherence tomography during sedation in young children with optic pathway gliomas","volume":"132","author":"Avery","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"(3)","key":"key\n\t\t\t\t20170511102259_NOU287C44","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ajo.2010.08.046","article-title":"Retinal nerve fiber layer thickness in children with optic pathway gliomas","volume":"151","author":"Avery","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"(6)","key":"key\n\t\t\t\t20170511102259_NOU287C45","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jaapos.2010.08.014","article-title":"Optical coherence tomography in the evaluation of neurofibromatosis type-1 subjects with optic pathway gliomas","volume":"14","author":"Chang","year":"2010","journal-title":"J AAPOS"},{"issue":"(3)","key":"key\n\t\t\t\t20170511102259_NOU287C46","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1167\/iovs.13-13119","article-title":"Ganglion cell layer-inner plexiform layer thickness and vision loss in young children with optic pathway gliomas","volume":"55","author":"Gu","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"(5)","key":"key\n\t\t\t\t20170511102259_NOU287C47","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/NEN.0b013e3181a3240b","article-title":"Optic nerve dysfunction in a mouse model of neurofibromatosis-1 optic glioma","volume":"68","author":"Hegedus","year":"2009","journal-title":"J Neuropathol Exp Neurol"},{"issue":"(16)","key":"key\n\t\t\t\t20170511102259_NOU287C48","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1523\/JNEUROSCI.3994-09.2010","article-title":"Defective cAMP generation underlies the sensitivity of CNS neurons to neurofibromatosis-1 heterozygosity","volume":"30","author":"Brown","year":"2010","journal-title":"J Neurosci"},{"issue":"(2)","key":"key\n\t\t\t\t20170511102259_NOU287C49","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ana.24093","article-title":"Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1","volume":"75","author":"Diggs-Andrews","year":"2014","journal-title":"Ann Neurol"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/17\/5\/670\/16860353\/nou287.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T08:25:49Z","timestamp":1565857549000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-lookup\/doi\/10.1093\/neuonc\/nou287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,21]]},"references-count":49,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,9,21]]},"published-print":{"date-parts":[[2015,5]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/nou287","relation":{},"ISSN":["1523-5866","1522-8517"],"issn-type":[{"value":"1523-5866","type":"electronic"},{"value":"1522-8517","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9,21]]}}}